+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hypertension is a risk factor of recurrent thrombosis in antiphospholipid antibodies positive systemic lupus erythematodes patients



Hypertension is a risk factor of recurrent thrombosis in antiphospholipid antibodies positive systemic lupus erythematodes patients



Lupus 7(Suppl. 2): S224




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031758170

Download citation: RISBibTeXText


Related references

Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thrombosis and Haemostasis 76(6): 916-924, 1996

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis and Rheumatism 61(1): 29-36, 2009

Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Lupus 13(12): 927-933, 2005

Lupus nephritis and Raynaud's phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies. Clinical Rheumatology 27(3): 345-351, 2007

Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome. British Journal of Rheumatology 34(9): 873-881, 1995

Increased prevalence of anti-heparin platelet factor 4 antibodies in antiphospholipid antibody-positive patients without systemic lupus erythematosus. 2007

Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Thrombosis and Haemostasis 76(4): 514-517, 1996

Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus. Lupus 16(10): 810-816, 2007

Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study. Clinical Rheumatology 35(2): 333-340, 2016

Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Annals of the Rheumatic Diseases 48(5): 358-361, 1989

Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Blood Coagulation and Fibrinolysis 3(4): 407-414, 1992

Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders. Israel Journal of Medical Sciences 28(1): 9-15, 1992

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus A meta-analysis. Lupus 5(5): 519, 1996

FRI0319The analysis of risk and protective factors for thrombosis in systemic lupus erythematosus with or without antiphospholipid antibodies. Annals of the Rheumatic Diseases 72(Suppl 3): A482.2-A482, 2013

Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis. Lupus 6(5): 467-473, 1997